Article
Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.
Journal of the National Cancer Institute - 19 Dec 2012
Amaral André F S, Méndez-Pertuz Marinela, Muñoz Alberto, Silverman Debra T, Allory Yves, Kogevinas Manolis, Lloreta Josep, Rothman Nathaniel, Carrato Alfredo, Rivas del Fresno Manuel, Real Francisco X, Malats Núria
Abstract excerpt
BACKGROUND: Previous evidence suggests that 25-hydroxyvitamin D(3) [25(OH)D(3)] protects against several cancers. However, little is known regarding urothelial bladder cancer (UBC). We analyzed the association between plasma 25(OH)D(3) and overall risk of UBC, as well as according to stage and FG...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
